Contrast Media

Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.

ITN Wins Jesse H. Neal Award for Best Technical Content
News | Radiology Business | April 24, 2019

April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H. Neal Award winner in the Best...

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis

One of the most controversial issues in radiology in recent years has been the use of...

GU12171120

GU12171120

Sponsored Content | Case Study | Contrast Media Injectors | April 02, 2019

The continuing search for advantages to improve workflow has radiology departments constantly searching for new...

Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019

March 18, 2019 — Brain ...

Ultrasound Societies Urge FDA to Remove "Black Box" on Ultrasound Contrast Agents
News | Ultrasound Imaging | March 07, 2019

March 7, 2019 — National and international ...

Sponsored Content | Case Study | Contrast Media | January 30, 2019

The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of...

Sponsored Content | Videos | Contrast Media | January 22, 2019

ITN Contributing Editor Greg Freiherr speaks with...

Videos | Artificial Intelligence | December 21, 2018

Enhao Gong, Ph.D., founder of Subtle Medical, an artificial intelligence (AI) company that develops products to help...

Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018
News | Interventional Radiology | December 12, 2018

December 12, 2018 — Guerbet LLC USA highlighted new and next-level product offerings and partnerships in...

VigiLanz and Cincinnati Children's Commercialize Real-Time Acute Kidney Injury Tracking
News | Contrast Media | November 30, 2018

November 30, 2018 — VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration...

Artificial Intelligence May Help Reduce Gadolinium Dose in MRI

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

News | Contrast Media | November 27, 2018

November 27, 2018 — Researchers are using...

Guerbet Showcases Ongoing Collaboration With IBM Watson at RSNA 2018
News | Clinical Decision Support | November 21, 2018

November 21, 2018 — Guerbet LLC USA will feature its digital solutions including its ongoing collaboration with IBM...

Voyageur Minerals to Begin Manufacturing Barium Contrast Products With Chief Medical Supply
News | Contrast Media | November 14, 2018

November 14, 2018 — Voyageur Minerals Ltd. signed a joint venture agreement with Chief Medical Supply Ltd (CM) of...

Osprey Medical and GE Healthcare Launch Acute Kidney Injury Educational Program
News | Angiography | September 25, 2018

September 21, 2018 — Osprey Medical announced a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys...

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns, as seen in this MRI.

News | Contrast Media | September 12, 2018

In February 2018, a workshop was held at the National Institutes of Health (NIH) in Bethesda, Maryland, to explore...

Scientists Develop New MRI Tool for Cancer Diagnosis and Therapy

Researchers in the laboratory ‘Biomedical Nanomaterials’ of NUST MISIS. Image courtesy of PR Newsfoto/NUST MISIS.

News | Oncology Diagnostics | August 24, 2018

August 24, 2018 — A European research group has developed a system that allows doctors to both improve the accuracy...

Iron Outperforms Gadolinium as MRI Contrast Agent

Scientists at Rice's Laboratory for Nanophotonics added iron chelates (blue) and fluorescent dye (red) to multi-layered gold nanomatryoshkas to create particles that can be used for disease therapy and diagnostics. The "theranostic" nanoparticles have a core of gold (left) that is covered by silica containing the diagnostic iron and dye, which is covered by an outer shell of gold. The particles are about 20 times smaller than a red blood cell, and by varying the thickness of the layers, LANP scientists can tune the nanomatryoshkas to convert light into cancer-killing heat. (Image courtesy of Luke Henderson/Rice University)

News | Contrast Media | August 22, 2018

August 22, 2018 — Rice University nanoscientists have demonstrated a method for loading iron inside nanoparticles to...

Guerbet Partners With Imalogix on Dose Optimization With Artificial Intelligence
News | Radiation Dose Management | August 14, 2018

August 14, 2018 — Guerbet LLC USA announced a commercial partnership with Imalogix, a provider of...

Videos | Contrast Media | August 03, 2018

Lawrence Tanenbaum, M.D., FACR, vice president and director of advanced imaging at RadNet, discusses the latest...